Ambrisentan
Ambrisentan is an endothelin receptor antagonist used by specialists for selected Pulmonary Arterial Hypertension. It can cause severe fetal harm and fluid retention.
Key points
- The pulmonary-hypertension diagnosis and treatment combination must be confirmed by a specialist.
- Pregnancy prevention and testing requirements apply where pregnancy is possible.
- Rapid swelling, sudden breathlessness, fainting or possible pregnancy needs urgent contact with the treating team.
Listings are for comparison and general information; suitability and supply depend on specialist and pharmacy checks, pregnancy safeguards, monitoring and prescription requirements.
Important safety checks
Pregnancy potential, liver function, haemoglobin, fluid retention and other pulmonary-hypertension medicines require review. Reduced sperm counts may occur. New lung oedema can indicate a different underlying vascular condition.
When to seek urgent care
Seek urgent help for severe or sudden breathlessness, fainting, chest pain, rapid weight gain or swelling, jaundice, coughing frothy sputum or possible pregnancy.